CN101366884A - 一种降血脂、降血糖复方制剂的制备工艺 - Google Patents

一种降血脂、降血糖复方制剂的制备工艺 Download PDF

Info

Publication number
CN101366884A
CN101366884A CNA2008100512216A CN200810051221A CN101366884A CN 101366884 A CN101366884 A CN 101366884A CN A2008100512216 A CNA2008100512216 A CN A2008100512216A CN 200810051221 A CN200810051221 A CN 200810051221A CN 101366884 A CN101366884 A CN 101366884A
Authority
CN
China
Prior art keywords
powder
preparation
supernatant
ethanol
hour
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2008100512216A
Other languages
English (en)
Other versions
CN101366884B (zh
Inventor
王茂祥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAOXIANG GROUP JILIN PHARMACEUTICAL CO Ltd
Original Assignee
MAOXIANG GROUP JILIN PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAOXIANG GROUP JILIN PHARMACEUTICAL CO Ltd filed Critical MAOXIANG GROUP JILIN PHARMACEUTICAL CO Ltd
Priority to CN200810051221A priority Critical patent/CN101366884B/zh
Publication of CN101366884A publication Critical patent/CN101366884A/zh
Priority to PCT/CN2009/001065 priority patent/WO2011011905A1/zh
Application granted granted Critical
Publication of CN101366884B publication Critical patent/CN101366884B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/424—Gynostemma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/884—Alismataceae (Water-plantain family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明公开一种降血脂、降血糖复方制剂的制备工艺，取人参灭菌，干燥，粉碎得人参粉，备用；将苍术、山楂、泽泻加水冷浸，煎煮，减压浓缩成浓缩液；加乙醇醇沉取上清液，减压回收乙醇，得精制浸膏，加入人参粉和绞股蓝总甙粉，混合，干燥、粉碎，加入乙醇，制软材，干燥造粒，装胶囊。本发明具有制备步骤科学，工艺参数合理，原料有效成分损失小，产量高、质量稳定、成本低。

Description

一种降血脂、降血糖复方制剂的制备工艺
技术领域
本发明提供一种降低血脂、降血糖复方制剂的制备工艺，属于中医制药技术领域。
背景技术
本发明涉及的“降血脂、降血糖复方制剂”是由苍术10-20份、山楂10-20份、泽泻5-10份、人参1-5份、绞股蓝总甙0.25-2份组成的复方制剂，该复合制剂现有的制备方法简单的粉碎成粉混匀制成胶囊，工艺参数还不够科学，原料有效成分不能得到最大限度的提取，因此，也影响了其使用效果。
发明内容
本发明公开一种降低血脂、降血糖复方制剂的制备工艺，具有工艺参数合理，原料有效成分损失小，生物利用度高的特点。
本发明的制备工艺如下：
1、取人参1-5份，捡去杂质，洗净，80-200℃灭菌5-60min，干燥，粉碎，过40-200目筛，得人参粉，备用；
2、苍术10-20份、山楂10-20份、泽泻5-10份加水冷浸0.5-2小时，煎煮2～4次，每次0.5～2小时，煎液滤过，合并滤液，减压浓缩至相对密度为1-1.30(波美计，30-80℃)，放出，得浓缩液；
3、在步骤2的浓缩液中加乙醇到含醇量10％-95％，静置12小时，取上清液，沉淀用10％-95％乙醇洗二次，溶液并入上清液，上清液减压回收乙醇，得精制浸膏；
4、取步骤3的精制浸膏，加入步骤1的人参粉和0.25-2份绞股蓝总甙粉，混合，在60℃以下减压干燥、粉碎，过40-200目筛，得药粉，加入其10％-30％药粉重量的0％-95％浓度的乙醇，混匀消毒，制软材，过12-18目筛制粒，在60℃以下干燥2-3小时，装胶囊。
功效成分含量：每100g含总皂甙(以人参皂甙Re计)4.5g，总黄酮(以芦丁计)131.5mg。
用法用量：3次/日；0.8～1.2g/次。
本发明的积极效果在于：制备步骤科学，工艺参数合理，原料有效成分损失小，产量高、质量稳定、成本低。
具体实施方式
通过以下实施例进一步举例描述本发明，并不以任何方式限制本发明，在不背离本发明的技术解决方案的前提下，对本发明所作的本领域普通技术人员容易实现的任何改动或改变都将落入本发明的权利要求范围之内。
实施例1
1、取人参30kg，捡去杂质，洗净，置卧式灭菌柜中200℃灭菌60min，取出，干燥，粉碎，过40-200目筛，得人参粉，备用。
2、苍术160kg、山楂160kg、泽泻75kg加水冷浸0.5-2小时，煎煮2次，每次1小时，煎液滤过，合并滤液，减压浓缩至相对密度为1-1.30(波美计，30-80℃)，放出，得浓缩液。
3、在相对密度为1-1.30(波美计，30-80℃)的浓缩液中加乙醇至含醇量75％，静置12小时，取上清液，沉淀用85％乙醇洗二次，溶液并入上清液，上清液减压回收乙醇，得精制浸膏。
4、取精制浸膏，加入步骤1的人参粉和11kg绞股蓝总甙粉，混合，在60℃以下减压干燥、粉碎，过40-200目筛，得药粉，加入30％药粉重量的65％浓度的乙醇，混匀消毒，制软材，过12-18目筛制粒，在60℃以下干燥2-3小时，装胶囊。每100g含总皂甙(以人参皂甙Re计)4.5g，总黄酮(以芦丁计)142.5mg
实施例2
1、取人参1kg，捡去杂质，洗净，置卧式灭菌柜中180℃，灭菌10min，取出，干燥，粉碎，过40-200目筛，得人参粉，备用。
2、苍术10kg、山楂15kg、泽泻5kg加水冷浸0.5-2小时，煎煮4次，每次1小时，煎液滤过，合并滤液，减压浓缩至相对密度为1-1.30(波美计，30-80℃)，放出，得浓缩液。
3、在相对密度为1-1.30(波美计，30-80℃)的浓缩液中加乙醇至含醇量50％，静置12小时，取上清液，沉淀用75％乙醇洗二次，溶液并入上清液，上清液减压回收乙醇，得精制浸膏。
4、取精制浸膏，加入人参粉、1kg绞股蓝总甙粉，混合，在60℃以下减压干燥、粉碎，过40-200目筛，得药粉，加入20％药粉重量的95％浓度的乙醇，混匀消毒，制软材，过12-18目筛制粒，在60℃以下干燥2-3小时，装胶囊。每100g含总皂甙(以人参皂甙Re计)4.9g，总黄酮(以芦丁计)139.5mg。
实施例3
1、取人参5kg，捡去杂质，洗净，置卧式灭菌柜中200℃，灭菌60min，取出，干燥，粉碎，过40-200目筛，得人参粉，备用。
2、苍术20kg、山楂10kg、泽泻10kg加水冷浸2小时，煎煮3次，每次1小时，煎液滤过，合并滤液，减压浓缩至相对密度为1-1.30(波美计，30-80℃)，放出，得浓缩液。
3、在相对密度为1-1.30(波美计，30-80℃)的浓缩液中加乙醇至含醇量85％，静置12小时，取上清液，沉淀用75％乙醇洗二次，溶液并入上清液，上清液减压回收乙醇，得精制浸膏。
4、取精制浸膏，加入人参粉、2kg绞股蓝总甙粉，混合，在60℃以下减压干燥、粉碎，过40-200目筛，得药粉，加入15％药粉重量的水，混匀消毒，制软材，过12-18目筛制粒，在60℃以下干燥2-3小时，装胶囊。每100g含总皂甙(以人参皂甙Re计)4.5g，总黄酮(以芦丁计)131.5mg。

Claims (1)

1.一种降血脂、降血糖复方制剂的制备工艺，其特征在于包括以下步骤：
1)取人参1-5份，于80-200℃灭菌5-60分钟，干燥，粉碎，过40-200目筛；
2)苍术10-20份、山楂10-20份、泽泻5-10份加水冷浸0.5-2小时，煎煮2～4次，每次0.5～2小时，煎液滤过，合并滤液，减压浓缩至相对密度为1-1.30(波美计，30-80℃)，得浓缩液；
3)在步骤2的浓缩液中加乙醇到含醇量10％-95％，静置12小时，取上清液，将沉淀用10％-95％乙醇洗二次，溶液并入上清液，将上清液减压蒸馏，得精制浸膏；
4)取步骤3的精制浸膏，加入步骤1的人参粉和0.25-2份绞股蓝总甙粉，混合，在60℃以下减压干燥、粉碎，过40-200目筛，得药粉，加入其10％-30％药粉重量的0％-95％浓度的乙醇，混匀过12-18目筛制粒，在60℃以下干燥2-3小时，装胶囊。
CN200810051221A 2008-09-26 2008-09-26 一种降血脂、降血糖复方制剂的制备工艺 Expired - Fee Related CN101366884B (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN200810051221A CN101366884B (zh) 2008-09-26 2008-09-26 一种降血脂、降血糖复方制剂的制备工艺
PCT/CN2009/001065 WO2011011905A1 (zh) 2008-09-26 2009-09-22 一种降血脂、降血糖复方制剂的制备工艺

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810051221A CN101366884B (zh) 2008-09-26 2008-09-26 一种降血脂、降血糖复方制剂的制备工艺

Publications (2)

Publication Number Publication Date
CN101366884A true CN101366884A (zh) 2009-02-18
CN101366884B CN101366884B (zh) 2010-05-12

Family

ID=40410976

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810051221A Expired - Fee Related CN101366884B (zh) 2008-09-26 2008-09-26 一种降血脂、降血糖复方制剂的制备工艺

Country Status (2)

Country Link
CN (1) CN101366884B (zh)
WO (1) WO2011011905A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010037256A1 (zh) * 2008-09-26 2010-04-08 Wang Maoxiang 降低血脂和血糖的组合物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526264B (zh) * 2012-01-04 2013-09-18 山东省中医药研究院 一种具有降血脂功效的中药制剂及其制备方法
CN102600228B (zh) * 2012-04-10 2013-06-12 湖南麓山天然植物制药有限公司 一种绞股蓝总苷颗粒中绞股蓝总苷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1255149C (zh) * 2004-08-09 2006-05-10 广东庆发药业有限公司 一种药物组合物
CN100484408C (zh) * 2006-11-24 2009-05-06 朱迅 一种降脂健身茶及其制作方法
CN101366882B (zh) * 2008-09-26 2010-04-21 茂祥集团吉林制药有限公司 一种具有降低血脂血糖功能的复方制剂

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010037256A1 (zh) * 2008-09-26 2010-04-08 Wang Maoxiang 降低血脂和血糖的组合物

Also Published As

Publication number Publication date
CN101366884B (zh) 2010-05-12
WO2011011905A1 (zh) 2011-02-03

Similar Documents

Publication Publication Date Title
CN101965883B (zh) 一种减肥茶及制备方法
CN1228968A (zh) 从竹叶中提取黄酮类化合物浸膏或粉剂的生产方法
CN102187926B (zh) 一种山楂核抹茶或山楂核饮料的加工工艺
CN105724646A (zh) 一种问荆三七叶茶膏的制作方法
CN101366884B (zh) 一种降血脂、降血糖复方制剂的制备工艺
CN105732741B (zh) 紫苏叶提取花色苷和熊果酸的方法
CN1857610A (zh) 一种含乌药叶提取物的保健品及其制备方法
CN106306247A (zh) 红药子复合花茶的制备方法
CN103830292A (zh) 罗布麻总黄酮提取物及其制备方法
CN101703554B (zh) 一种菟丝子总黄酮的制备及应用
CN102885172B (zh) 一种荷叶减肥袋泡茶及其生产方法
CN109568214A (zh) 一种百香果壳提取物制备方法
CN103690588A (zh) 一种从绞股蓝中提取精制绞股蓝总苷的生产方法
CN101966261A (zh) 一种治疗高血压的药物及其制备方法
CN103948704A (zh) 一种悬钩子复合物及其制备方法
CN102727540A (zh) 一种杨梅叶提取物的制备方法
CN103830490A (zh) 一种富硒怀山药提取物的提取方法
CN102772660A (zh) 新型同时降血脂和降血糖的中药组合物及其制法
CN101284058A (zh) 一种解酒剂及其制备方法
CN1123609A (zh) 天然解酒茶
CN101716226A (zh) 一种用于防治流感的保健药品及其制备方法
CN101190278A (zh) 降血脂保健茶及其制备方法
CN1161144C (zh) 排毒降脂胶囊及其制备工艺
CN1698708A (zh) 妇科白带胶囊及其制备方法
CN100589823C (zh) 一种具有保肝作用的保健胶囊

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100512

Termination date: 20150926

EXPY Termination of patent right or utility model